Poster Session One
Poster Session Two
Poster Session Three
Plenary Abstracts
Symposium Abstracts
Parallel Session Abstracts
Print this page
Poster Session One
Late breaking abstracts: Therapies – clinical testing
LB22 – LB23
LB22: Defining who benefits from treatment for melanoma
LB23: Early results of a phase I/II trial, showing humoral and cellular responses to an anti- CEA DNA vaccine
